Search

Your search keyword '"Plavix (Medication)"' showing total 468 results
Start Over Descriptor "Plavix (Medication)" Topic news, opinion and commentary
468 results on '"Plavix (Medication)"'

3. GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS- invites tenders for Acquisition of the Medication Clopidogrel, 75 Mg Tablet, Trademark Plavix, Igss Code 185, Required by Different Medical Units of the Institute

Subjects
Company acquisition/merger, News, opinion and commentary, Plavix (Medication)
Abstract

GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS-, Guatemala has invited tenders for Acquisition of the Medication Clopidogrel, 75 Mg Tablet, Trademark Plavix, Igss Code 185, Required by Different Medical Units of [...]

Published
2024

4. Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit

Subjects
Bristol-Myers Squibb Co. -- Planning, The Associated Press -- Planning, Sanofi S.A. -- Planning, News agencies -- Planning, Pharmaceutical industry -- Planning, Company business planning, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

Byline: The Associated Press HONOLULU (AP) A Hawaii court has ordered the manufacturers and distributors of the blood thinner Plavix to pay the state a combined $916 million after finding [...]

Published
2024

6. CytoSorbents to present second analysis from STAR Registry at EACTS meeting

Subjects
Ticagrelor -- Analysis, Business, News, opinion and commentary, Brilinta (Medication), Pradaxa (Medication), Effient (Medication), Savaysa (Medication), Plavix (Medication), Xarelto (Medication)
Abstract

CytoSorbents announced the upcoming original presentations at the 37th European Association of Cardio-Thoracic Surgery Annual Meeting in Vienna, Austria, from October 4-7, 2023, including the second analysis from the international [...]

Published
2023

7. Medicinal notes must ‘be clearer’ after review; Hospital Authority calls for accuracy from staff following wrong treatment for patients

Author

Magramo, Kathleen

Subjects
Medication errors, Medical care -- Quality management, News, opinion and commentary, Plavix (Medication)
Abstract

Hong Kong’s Hospital Authority has reminded staff to clearly note down prescription instructions and store details accurately in record-keeping systems after two recent miscommunications led to wrong medication being given [...]

Published
2021

8. Bristol-Myers, Sanofi must pay $834 million over blood-thinner

Subjects
Bristol-Myers Squibb Co. -- Joint ventures, Sanofi S.A. -- Joint ventures, Consumer protection, Pharmaceutical industry -- Joint ventures, Company joint venture, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

HAWAII Bristol-Myers Squibb and Sanofi were ordered to pay the state of Hawaii more than $834 million for illegally marketing their blockbuster blood-thinning drug Plavix in a manner that put [...]

Published
2021

9. USING UDAP IN AN ACTION AGAINST THE MANUFACTURERS OF THE ANTIPLATELET MEDICATION PLAVIX

Subjects
Bristol-Myers Squibb Co., Sanofi S.A., Mephenytoin, Exemplary damages, Judgments, Pharmaceutical industry, News, opinion and commentary, Plavix (Medication)
Abstract

WASHINGTON -- The following information was released by the National Association Of Attorneys General: In 2014, the State of Hawai'i sued the manufacturers of the antiplatelet medication Plavix in state [...]

Published
2021

10. FEDERAL COURTS SHOULDN'T 'ABSTAIN' FROM HEARING FEDERAL CIVIL RIGHTS CLAIMS

Subjects
Sanofi S.A., Civil rights -- France, Exemplary damages, Pharmaceutical industry, News, opinion and commentary, Plavix (Medication)
Abstract

WASHINGTON -- The following information was released by the Cato Institute: By Ilya Shapiro and Mallory Reader Hawaii sued Bristol'É Myers Squibb (BMS) and Sanofi for failing to make the [...]

Published
2021

11. Baron & Budd Obtains $834 Million Judgment Against Global Drug Manufacturers on Behalf of State of Hawai'i

Subjects
Bristol-Myers Squibb Co., Sanofi Synthelabo Inc., Pharmaceutical industry, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

LOS ANGELES: Baron & Budd, P.C. has issued the following news release: Today, the nationally recognized attorneys from Baron & Budd obtained an $834,012,000 judgment against global pharmaceutical companies, Bristol-Myers [...]

Published
2021

12. This Biden Superfan Can't Stop Tweeting Fake Garbage

Subjects
COVID-19, General interest, News, opinion and commentary, Twitter (Online social network), Plavix (Medication)
Abstract

Minutes before Donald Trump announced via tweet that he had COVID-19, Joe Biden superfan Jon Cooper tried to break some news of his own about the president's health. Trump, Cooper [...]

Published
2020

13. B-MS, SANOFI CLAIM HAWAII IS VIOLATING THEIR FREE SPEECH IN PLAVIX SUIT

Subjects
Bristol-Myers Squibb Co. -- Cases, Sanofi S.A. -- Cases, Clopidogrel -- Cases, Freedom of speech -- Cases, Pharmaceutical industry -- Cases, Cardiovascular agents -- Cases, Company legal issue, News, opinion and commentary, Plavix (Medication)
Abstract

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Zachary Brennan Bristol-Myers Squibb (B-MS) and Sanofi filed a complaint this week in the US [...]

Published
2020

14. United States Courts Opinions: United States District Court Western District of LOUISIANA : BOAT SERVICE OF GALVESTON, INC. CIVIL ACTION VERSUS No.: 17-7210 NRE POWER SYSTEMS, INC., et al

Subjects
United States. Supreme Court, DePuy Orthopaedics Inc., Scania AB, Bristol-Myers Squibb Co., Moffett Engineering Ltd., Materials handling equipment industry, Medical equipment industry, Pharmaceutical industry, Boats, Electric power systems -- Sweden -- Ireland -- United States -- Texas -- Louisiana -- California -- Mississippi, Truck industry, Jurisdiction, News, opinion and commentary, Plavix (Medication)
Abstract

Washington: United States District Court Western District of LOUISIANA has issued the following order: UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA BOAT SERVICE OF GALVESTON, INC. CIVIL ACTION VERSUS [...]

Published
2019

15. Spartan Bioscience Announces Publication of Landmark POPular Genetics Clinical Trial in the New England Journal of Medicine

Subjects
Biotechnology industry -- Product development, Clinical trials, Cardiac patients, Cytochrome P-450, Blood platelets -- Aggregation, Business, News, opinion and commentary, Brilinta (Medication), Effient (Medication), Plavix (Medication)
Abstract

2,488-Patient trial demonstrates precision medicine genotyping results in better patient outcomes, lower incidents of bleeding OTTAWA, Canada, Sept. 5, 2019 /PRNewswire-PRWeb/ -- Spartan Bioscience today announced that the New England [...]

Published
2019

16. Sanofi delivered solid growth in Q2 2019

Subjects
United States. Food and Drug Administration, Emerging markets -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, European Union, American Society of Clinical Oncology, Aubagio (Medication), Dupixent (Medication), Eloctate (Medication), Alprolix (Medication), Synvisc (Medication), Lovenox (Medication), Libtayo (Medication), Plavix (Medication), Toujeo (Medication), Cablivi (Medication), Renvela (Medication), Avapro (Medication), Lantus (Medication), Praluent (Medication), RenaGel (Medication), Lemtrada (Medication)
Abstract

FRANCE: Sanofi has issued the following news release: Sanofi delivered solid growth in Q2 2019 Q2 2019 Change Change at CER H1 2019 Change Change at CER IFRS net sales [...]

Published
2019

17. Global Ischemic Stroke Market and Forecast Analysis 2019-2024: Market Growth will Slow as Plavix Continues to Lose Market Share as Generic Clopidogrel Uptake Increases

Subjects
Clopidogrel -- Forecasts and trends, Stroke -- Forecasts and trends, Ischemia -- Forecasts and trends, Death, Company growth, Market trend/market analysis, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Ischemic Stroke Market and Forecast Analysis 2024' drug pipelines has been added to ResearchAndMarkets.com's offering. Stroke is the second [...]

Published
2019

18. Global Ischemic Stroke Market and Forecast Analysis to 2024 - Activase will Continue to Experience Strong Uptake while Aggrenox and Plavix Face Declining Sales

Subjects
Stroke (Disease), Ischemia, Clopidogrel -- Statistics, Business, News, opinion and commentary, Plavix (Medication)
Abstract

DUBLIN, June 19, 2019 /PRNewswire/ -- The 'Ischemic Stroke Market and Forecast Analysis 2024' drug pipelines has been added to ResearchAndMarkets.com's offering. Stroke is the second most common cause of [...]

Published
2019

19. Sanofi delivers 2018 EPS business growth of 5.1% at CER

Subjects
Economic forecasting, General interest, News, opinion and commentary, Dupixent (Medication), Lantus (Medication), Plavix (Medication), Toujeo (Medication)
Abstract

Amsterdam: SANOFI has issued the following news release:Sanofi delivers 2018 EPS business growth of 5.1% at CERQ4 2018ExchangeExchangeat CER2018ExchangeExchangeat CERIFRS net sales reportedEUR8,997m+ 3.5%+ 3.9%EUR34,463m-1.7%+ 2.5%IFRS net income reportedEUR254m+ 101.6%-EUR4,306m-48.8% [...]

Published
2019

20. Federal Circuit Court of Australia Decision: Commonwealth of Australia v Sanofi-Aventis [2015] FCA 384

Subjects
Australia. High Court of Australia, AstraZeneca PLC, Pharmaceutical industry, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

Canberra ACT: Federal Circuit Court of Australia has issued the following decision 24 April 2015: FEDERAL COURT OF AUSTRALIA Commonwealth of Australia v Sanofi-Aventis [2015] FCA 384 Citation: Commonwealth of [...]

Published
2018

21. UPMC to use genetic tests in heart patient regimen

Subjects
Genetic testing, Medical tests, Cardiac patients -- Care and treatment, Prescriptions (Drugs), General interest, News, opinion and commentary, Plavix (Medication)
Abstract

Byline: Ben Schmitt Feb. 10--One of the most common treatments to open clogged arteries is getting a high-tech enhancement at UPMC. Heart disease patients implanted with coronary stents will undergo [...]

Published
2016

22. WOCKHARDT GETS USFDA NOD FOR PLAVIX GENERIC (marketing immediately in US)

Subjects
United States. Food and Drug Administration, Bristol-Myers Squibb Co., Generic drugs, Pharmaceutical industry, Banking, finance and accounting industries, Business, Business, international, News, opinion and commentary, Plavix (Medication)
Abstract

Wockhardt has received final approval from the United States Food and Drug Administration (USFDA) for marketing tablets of clopidogrel bisulfate, used to help reduce risk of heart attack or stroke. [...]

Published
2012

23. INDIAN PHARMA COMPANIES VIE FOR BIG PIE OF $6.7-BILLION GENERIC 'PLAVIX' IN US (indicated for acute coronary syndrome and recent stroke)

Subjects
United States. Food and Drug Administration, Coronary heart disease, Stroke (Disease), Generic drugs, Pharmaceutical industry, Banking, finance and accounting industries, Business, Business, international, News, opinion and commentary, Plavix (Medication)
Abstract

Dr Reddy's Laboratories, Sun Pharmaceuticals and Aurobindo Pharma are aiming to capture a good chunk of the $6.7-billion clopidogrel tablets USP in the US market following approval from the US [...]

Published
2012

24. U.S. HIGH COURT SHUTS DOWN EXPANDED STATE JURISDICTION

Subjects
California Chamber of Commerce, California. Supreme Court, United States. Supreme Court, Bristol-Myers Squibb Co., Jurisdiction, Chambers of commerce, Pharmaceutical industry, News, opinion and commentary, Plavix (Medication)
Abstract

SACRAMENTO, CA -- The following information was released by the California Chamber of Commerce (CalChamber): In a decision released last week, the U.S. Supreme Court has limited one potential source [...]

Published
2017

25. U.S. Supreme Court limits where patients can sue drug companies

Subjects
United States. Supreme Court -- Cases, Bristol-Myers Squibb Co. -- Cases, Pharmaceutical industry -- Cases, Company legal issue, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

Byline: ALLEN CONE Dec. 31 (UPI) -- The U.S. Supreme Court on Monday limited where patients can sue drug companies for compensation from harmful effects. The justices, in an 8-1 [...]

Published
2017

26. SPECIFIC JURISDICTION OVER A DRUGMAKER DEBATED AT SCOTUS

Subjects
California. Supreme Court, United States. Supreme Court, Bristol-Myers Squibb Co., Jurisdiction, Legal liability, Pharmaceutical industry, News, opinion and commentary, American Association for Justice, Plavix (Medication)
Abstract

WASHINGTON -- The following information was released by the American Association for Justice (AAJ): Kate Halloran Last week, the U.S. Supreme Court heard oral arguments about whether a state can [...]

Published
2017

27. SUN SETTLES PLAVIX PATENT DISPUTE WITH SANOFI (patent for this drug expires on 17 May 2012)

Subjects
Bristol-Myers Squibb Co. -- Intellectual property, Generic drugs, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Banking, finance and accounting industries, Business, Business, international, News, opinion and commentary, Plavix (Medication)
Abstract

Sun Pharmaceutical Industries has settled its patent case with Bristol-Myers Squibb (BMS) and Sanofi over Plavix. The drug is used to inhibit blood clots in coronary artery disease. The patent [...]

Published
2011

29. DRL-SANOFI MULL OFF-COURT SETTLEMENT (to enable Sanofi Aventis and Bristol-Myers Squibb to retain the patent protection on Plavix until 2011)

Subjects
Bristol-Myers Squibb Co., Pharmaceutical industry, Banking, finance and accounting industries, Business, Business, international, News, opinion and commentary, Plavix (Medication)
Abstract

(From India Business Insight) Sanofi Aventis and Bristol-Myers Squibb have offered an out-of- court-settlement to Dr Reddy's Laboratories (DRL) for their drug Plavix. Plavix, a blood thinner, is the world's [...]

Published
2006

30. SANOFI-AVENTIS, BRISTOL OFFER TO SETTLE PLAVIX ISSUE WITH DRL (DRL and Apotex Inc have been challenging the Plavix patent since 2002)

Subjects
Apotex Inc., Pharmaceutical industry, Banking, finance and accounting industries, Business, Business, international, News, opinion and commentary, Plavix (Medication)
Abstract

(From India Business Insight) Sanofi-Aventis and Bristol-Myers Squibb Company, after settling a dispute with Apotex Inc that could keep US patent protection on their blood thinner drug Plavix until 2011, [...]

Published
2006

31. PATENT PROSPECT (Ranbaxy wins enantiomer patent challenge in UK and is expected to win in the US and a few European markets)

Subjects
Banking, finance and accounting industries, Business, Business, international, News, opinion and commentary, Lexapro (Medication), Lipitor (Medication), Plavix (Medication)
Abstract

(From India Business Insight) In Oct 2005, a UK court ruled that a patent covering the calcium salt (atorvastatin calcium) was invalid. Technically it is described as enantiomer patent. The [...]

Published
2005

32. Plavix -Drug Insights

Subjects
Generic drugs, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

Nov 24, 2016 (M2 PRESSWIRE via COMTEX) -- Drug Report, 'Plavix- Drug Insights, 2016' highlights the Plavix marketed details, pipeline status and the Global API Manufacturers along with the location. [...]

Published
2017

33. STATE MAY EXERCISE SPECIFIC JURISDICTION OVER NONRESIDENTS' CLAIMS AGAINST DRUGMAKER

Subjects
Daimler AG, Bristol-Myers Squibb Co., Automobile industry, Pharmaceutical industry, Automobile Industry, News, opinion and commentary, Plavix (Medication)
Abstract

WASHINGTON -- The following information was released by the American Association for Justice (AAJ): Kate Halloran California courts may exercise specific jurisdiction over nonresidents' claims against a pharmaceutical company because [...]

Published
2016

34. Profile of Carolyn Hobbs, Vice President of Corcept Therapeutics Incorporated

Subjects
Corcept Therapeutics Inc. -- Officials and employees, Novartis AG -- Officials and employees, Sanofi S.A. -- Officials and employees, Vice presidents (Organizations), Pharmaceutical industry -- Officials and employees, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

Massachusetts: Following is the Profile of Carolyn Hobbs, Vice President of Corcept Therapeutics Incorporated: Ms. Hobbs joined Corcept as Vice President Corporate Affairs in April 2016. Carolyn brings over 20 [...]

Published
2016

35. Profile of Director Carolyn Hobbs, Vice President, Corporate Affairs of Corcept Therapeutics Inc

Subjects
Corcept Therapeutics Inc. -- Officials and employees, Novartis AG -- Officials and employees, Sanofi S.A. -- Officials and employees, Vice presidents (Organizations), Pharmaceutical industry -- Officials and employees, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

United States: Following is the Profile of Director Carolyn Hobbs, Vice President, Corporate Affairs of Corcept Therapeutics Inc: Ms. Hobbs joined Corcept as Vice President Corporate Affairs in April 2016. [...]

Published
2016

36. Study pitches customized medication

Subjects
Drugs, Cardiac patients, Prescriptions (Drugs), News, opinion and commentary, Sports and fitness, Plavix (Medication)
Abstract

Byline: Annemarie Carr Instead of prescribing drugs based solely off patients' medical records, Pitt's Philip Empey is looking into a new tactic -- basing prescriptions on patients' DNA. Empey, assistant [...]

Published
2016

37. Newt Gingrich Criticizes Ron Paul; North Korea Holds Funeral Services for Kim Jong-il; A Connecticut Homes Burns with Three

Subjects
Cable News Network. CNN International, Cable television broadcasting industry -- International economic relations, General interest, News, opinion and commentary, Arab League, Plavix (Medication)
Abstract

(BEGIN VIDEO CLIP) ALI VELSHI, CNN ANCHOR: Overwhelming grief on display in the streets of North Korea. Funeral services for the so-called dear leader, Kim Jong-Il. NEWT GINGRICH, GOP PRESIDENTIAL [...]

Published
2011

38. 5 mix-ups reported for drugs Pradax, Plavix

Subjects
Medication errors, Drugs -- Prescribing, Anticoagulants (Medicine), General interest, News, opinion and commentary, Plavix (Medication)
Abstract

Byline: CBC News Two prescription drugs, Pradax and Plavix, have similar names that have resulted in drug mix-ups in Canada, including harm to a patient, Health Canada warns. Boehringer Ingelheim [...]

Published
2011

39. Some antacids interact with Plavix more

Subjects
Anticoagulants (Medicine), Antacids, Proton pump inhibitors, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

Byline: CBC News Taking the blood thinner Plavix along with some prescription antacids can reduce the effectiveness of the blood clot prevention, Health Canada says. The department sent an advisory [...]

Published
2011

40. BRIEF: Prescription Drug Costs Expected To Plummet

Subjects
Generic drugs -- Economic aspects, Drugs -- Prescribing, General interest, News, opinion and commentary, Lipitor (Medication), Plavix (Medication)
Abstract

July 25--LOS ANGELES -- By the end of next year, seven of the 20 top selling prescription drugs will lose their patents, making way for less expensive generic versions. The [...]

Published
2011

41. EVENING NEWS for July 25, 2011, CBS

Subjects
CBS Inc. CBS News, Television broadcasting industry, General interest, News, opinion and commentary, Lipitor (Medication), Plavix (Medication)
Abstract

BOB SCHIEFFER, CBS NEWS ANCHOR: Tonight: With the debt deadline fast approaching, President Obama will address the nation as both parties scramble to come up with separate plans to cut [...]

Published
2011

42. Bristol-Myers to cut 3% of workforce

Subjects
Bristol-Myers Squibb Co. -- Downsizing, Pharmaceutical industry -- Downsizing, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

Byline: CBC News Drug maker Bristol-Myers Squibb, which employs more than 300 people across Canada, announced Thursday it is cutting three per cent of its global workforce. That amounts to [...]

Published
2010

43. The Mysterious Case of Kevin Xu

Subjects
Alzheimer's disease -- Drug therapy, News, opinion and commentary, Aricept (Medication), Casodex (Medication), Zyprexa (Medication), Viagra (Medication), Plavix (Medication)
Abstract

TEASE: DAN RATHER, DAN RATHER REPORTS GLOBAL CORRESPONDENT (Voiceover): Tonight, counterfeit from China the untold story of how a Chinese businessman tried to sneak millions of phony pills into American [...]

Published
2010

44. Some heartburn drugs raise risk of 2nd heart attack: study

Subjects
Antiulcer drugs, Heart attack -- Risk factors -- Drug therapy, Anticoagulants (Medicine), Heartburn -- Risk factors -- Drug therapy, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

Byline: CBC News Some heartburn medications commonly taken by people following a heart attack can significantly increase the risk of another heart attack, a new study suggests. In Wednesday's online [...]

Published
2009

45. U.S. judge issues permanent block on Apotex's generic Plavix

Subjects
Apotex Inc., Pharmaceutical industry, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

Byline: CBC News A U.S. judge has upheld the patent on the popular blood thinner Plavix and permanently blocked Toronto-based Apotex Inc. from selling its generic version of the drug [...]

Published
2007

46. Canadian court tosses Apotex appeal on generic Plavix

Subjects
Bristol-Myers Squibb Co., Apotex Inc., Sanofi S.A., Pharmaceutical industry, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

Byline: CBC News Drug makers Sanofi-aventis and Bristol-Myers Squibb claimed victory Thursday, saying a federal court dismissed an appeal that sought to open Canadian markets to Apotex's generic version of [...]

Published
2006

49. DNA device gains FDA approval

Subjects
United States. Food and Drug Administration, DNA, Biotechnology industry, Cardiac patients, General interest, News, opinion and commentary, Plavix (Medication)
Abstract

Byline: RICHARD BLACKWELL BIOTECHNOLOGY A Canadian biotech company has received a green light from U.S. regulators to sell an almost-instantaneous DNA testing device that could change the way genetic checks [...]

Published
2013

50. Plavix-Drug Insights,2014

Subjects
General interest, News, opinion and commentary, Plavix (Medication)
Abstract

Jan 14, 2015 (M2 PRESSWIRE via COMTEX) -- Summary 'Plavix - Drug Insights, 2014' provides Plavix marketed details and API Manufacturers details across the globe along with the location. In [...]

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results